The OARSI Clinical Trials Symposium occurred on Wednesday, October 20, 2021. Nearly 200 attendees learned from OARSI members and individuals from the FDA in a debate that continued previous discussions among OARSI, the FDA, and the Arthritis Foundation. If you missed the symposium or would like to view it again, you can view the recording.  

A special thank you to our sponsors: Biosplice, Nordic Bioscience, and Pfizer | Lilly. 

Published every Friday, the OARSI Weekly Briefing the single resource you need to stay up to date with OARSI & World Congress news, membership announcements, and happenings within the OARSI & OA community.

January 21, 2022 - Current Briefing

• Member Spotlight: Barbara Chan
• Call for Late Breaking Abstracts Now Open!
• Call for Committee Volunteers 
• and more! 

By popular demand, the OARSI Live webinar series is back. The next OARSI Live will be held on Wednesday, January 19 at 9:00 am ET.

This webinar will discuss a recently published genome-wide association study, “Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations” (DOI: 10.1016/j.cell.2021.07.038). The study represents the largest GWAS to date, identifying new genetic variants in both weight-bearing (knee, hip, and spine) and non-weight-bearing joints (hand, finger, and thumb). We will discuss methods, possible clinical implications, and future directions. Bring your questions and thoughts for an engaging discussion!

Learn More about OARSI